Innovative clinical trials for development of personalized cancer medicine

The cancer burden is increasing globally due in large part to the ageing of the population. A major challenge for healthcare systems is an increasing population of cancer patients who are not cured but are living longer with their cancer, making cancer into one of the major chronic diseases and one that carry a high economic burden due to the high cost of many cancer therapies. Innovative approaches to cancer prevention will be able to decrease some of these challenges. Developing better treatment strategies for disseminated disease remains one of the main goals to modify the growing patient population with chronic cancer disease.
Source: Molecular Oncology - Category: Cancer & Oncology Authors: Source Type: research